What Researchers Did
Researchers reported on a 32-year-old woman who received hyperbaric oxygen therapy for refractory BK virus-associated hemorrhagic cystitis after cord blood transplantation.
What They Found
Macroscopic hematuria resolved within one week of starting hyperbaric oxygen therapy, and microscopic hematuria was undetectable within two weeks. After 11 sessions, hematuria did not recur, and no significant side effects were observed.
What This Means for Canadian Patients
This case suggests that hyperbaric oxygen therapy could be a potential treatment option for severe, persistent BK virus-associated hemorrhagic cystitis in patients after cord blood transplantation. Patients experiencing similar complications might benefit from discussing this therapy with their healthcare providers.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
The primary limitation is that this is a single case report, which limits the generalizability of its findings to a broader patient population.